Organon & Co. Announces Board and Executive Compensation Changes
Ticker: OGN · Form: 8-K · Filed: Apr 15, 2025 · CIK: 1821825
| Field | Detail |
|---|---|
| Company | Organon & CO. (OGN) |
| Form Type | 8-K |
| Filed Date | Apr 15, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: management-change, compensation
TL;DR
Organon's board is shuffling, exec pay is changing. Keep an eye on this.
AI Summary
Organon & Co. announced on April 15, 2025, changes in its board of directors and executive compensation arrangements. The filing details the departure of certain officers and the election of new directors, alongside updates to compensatory arrangements for key executives.
Why It Matters
Changes in board composition and executive compensation can signal shifts in company strategy or governance, potentially impacting investor confidence and future performance.
Risk Assessment
Risk Level: medium — Changes in leadership and compensation can introduce uncertainty regarding future strategic direction and financial performance.
Key Players & Entities
- Organon & Co. (company) — Registrant
- April 15, 2025 (date) — Date of earliest event reported
- 001-40235 (other) — Commission File Number
- 46-4838035 (other) — I.R.S. Employer Identification No.
- 30 Hudson Street, Floor 33, Jersey City, NJ 07302 (address) — Principal executive offices
- (551) 430-6900 (phone_number) — Registrant's telephone number
FAQ
What specific roles have seen departures or appointments?
The filing indicates departures of certain officers and the election of new directors, but does not specify the exact roles in this summary.
When was the earliest event reported in this filing?
The earliest event reported was on April 15, 2025.
What is Organon & Co.'s Commission File Number?
Organon & Co.'s Commission File Number is 001-40235.
Where are Organon & Co.'s principal executive offices located?
Organon & Co.'s principal executive offices are located at 30 Hudson Street, Floor 33, Jersey City, NJ 07302.
What is the subject matter of this 8-K filing?
This 8-K filing concerns the departure of directors or certain officers, election of directors, appointment of certain officers, and compensatory arrangements of certain officers, as well as Regulation FD Disclosure.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on April 15, 2025 regarding Organon & Co. (OGN).